Adiposity clinical trials

Explore recruiting adiposity clinical trials.

Recruiting adiposity studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Adiposity trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Unravelling the local and systemic effects of primary surgery and perioperative use of ketorolac and pregabalin in primary breast cancer patients according to adiposity

Belgium

Therapeutic exploratory (Phase II) EU CTIS Study details

Randomized, double-blind, placebo-controlled study on the efficacy and safety of nicotinamide in patients with liver fibrosis.

Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

An Open-Label Study of Mibavademab (REGN4461), a Leptin Receptor Agonist, for the Treatment of Monogenic Obesity Due to Biallelic Loss of Function Variants of the LEP Gene

Germany

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Maridebart Cafraglutide in Adult Participants Without Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight (MARITIME-1)

Italy, Poland, Germany, Finland, Belgium, Denmark +2 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

SPI-62 as a Treatment for Adrenocorticotropic Hormone- dependent Cushing’s Syndrome

Bulgaria, Romania

Therapeutic exploratory (Phase II) EU CTIS Study details

Towards a treatment for accelerated maturation in girls testing spiomet in a randomised placebo controlled, multicentre study.

Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

Adiposity trials by city

Adiposity in Toronto Adiposity in Vancouver Adiposity in Montreal Adiposity in Calgary Adiposity in Edmonton Adiposity in Ottawa Adiposity in Winnipeg Adiposity in Quebec City Adiposity in Hamilton Adiposity in Kitchener Adiposity in London Adiposity in Halifax Adiposity in New York Adiposity in Los Angeles Adiposity in Chicago Adiposity in Houston

Adiposity clinical trials

Recruiting adiposity studies right now

Bariatric Surgery and Modulation of Perceived Satiety

ENDOPLY System in Humans: a Pilot Study

Impact of Microbiome-changing Interventions on Food Decision-making

AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

Time-Restricted Eating After Bariatric Surgery

Examination of How the Duration of Fasting and Temporary Stopping of GLP-1 Medications Affect the Amount of Food Left in the Stomach in People Using Liraglutide (Injected), Semaglutide (Taken by Mouth) or Semaglutide (Injected)

Increasing Food Literacy in Preschoolers to Reduce Obesity Risk

Comparison of Two Different Intensity Exercises on Young Women With Obesity

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Impact of Satiating Compounds and Hypocaloric Diet on Weight, Cardiometabolic and Osteoarticular Health in Obesity

Integrating Community LITE Programme as an Online Family-based Intervention to Combat Childhood Obesity

Vaginal Microbiome Seeding and Health Outcomes in Cesarean-delivered Neonates.

Also recruiting in Europe

Unravelling the local and systemic effects of primary surgery and perioperative use of ketorolac and pregabalin in primary breast cancer patients according to adiposity

Randomized, double-blind, placebo-controlled study on the efficacy and safety of nicotinamide in patients with liver fibrosis.

An Open-Label Study of Mibavademab (REGN4461), a Leptin Receptor Agonist, for the Treatment of Monogenic Obesity Due to Biallelic Loss of Function Variants of the LEP Gene

A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Maridebart Cafraglutide in Adult Participants Without Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight (MARITIME-1)

SPI-62 as a Treatment for Adrenocorticotropic Hormone- dependent Cushing’s Syndrome

Towards a treatment for accelerated maturation in girls testing spiomet in a randomised placebo controlled, multicentre study.

Adiposity trials by city

Other conditions